A year ago, on Aug. 14, 2024, the World Health Organization declared mpox a Public Health Emergency of International Concern.

A year ago, on August 14, 2024, the World Health Organization declared mpox a Public Health Emergency of International ...

WHO DG cautioned that drastic reductions in foreign assistance are now hampering access to key public health interventions.

In justifying the United States' rejection of updates to global health regulations, the Department of Health and Human Services and Secretary Robert F. Kennedy Jr. falsely claimed that the policy ...

The World Health Organization on Wednesday declared mpox a global public health emergency for the second time in two years, ...

Speaking during an International Health Regulations meeting, WHO Director-General Dr Tedros Adhanom Ghebreyesus said that the mpox upsurge still meets the threshold of a public health emergency.

This will be a randomized clinical trial comparing NV-387 treatment with the Standard of Care, to evaluate the dosing regimen for NV-387, the safety and tolerability of the dosing regimen in MPox ...

It expanded the scope of the regulations beyond a few specific diseases to include any public health emergency of international concern — biological, chemical, radiological, or nuclear in origin.

This will be a randomized clinical trial comparing NV-387 treatment with the Standard of Care, to evaluate the dosing regimen for NV-387, the safety and tolerability of the dosing regimen in MPox ...

While vaccination has started, overall, the uptake of available vaccines has remained lower than anticipated due to logistical, operational, and financial barriers, according to the report of the ...

This will be a randomized clinical trial comparing NV-387 treatment with the Standard of Care, to evaluate the dosing regimen for NV-387, the safety and tolerability of the dosing regimen in MPox ...

SHELTON, CONNECTICUT / ACCESS Newswire / July 16, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American: NNVC ) (the "Company"), and a clinical stage, leading global pioneer in ...